Showing results (1-10 of 278) with videos related to

Sort By:
Pageof 28
Atherosclerosis|February 17, 2019
HDL cholesterol and ASCVD risk stratification: A debatePhilip Barter, Jacques Genest
The Canadian Journal of Cardiology|September 8, 2006
Combination of statin and ezetimibe for the treatment of dyslipidemias and the prevention of coronary artery diseaseJacques Genest
The Canadian Journal of Cardiology|August 17, 2004
Preventive cardiology: move over low density lipoprotein cholesterol, hello C-reactive protein?Jacques Genest
Cardiology in Review|January 16, 2002
Genetics and prevention: a new look at high-density lipoprotein cholesterolJacques Genest
The Canadian Journal of Cardiology|April 14, 2010
C-reactive protein: risk factor, biomarker and/or therapeutic target?Jacques Genest
Endocrinology and Metabolism Clinics of North America|May 26, 2004
Metabolic abnormalities: high-density lipoproteinsPhilip Barter
Atherosclerosis. Supplements|April 13, 2005
The inflammation: lipoprotein cyclePhilip Barter
Atherosclerosis. Supplements|July 11, 2006
Managing diabetic dyslipidaemia--beyond LDL-C:HDL-C and triglyceridesPhilip Barter
Atherosclerosis. Supplements|December 14, 2011
HDL-C: role as a risk modifierPhilip Barter
Clinical and Experimental Nephrology|September 21, 2013
Lipoprotein metabolism and CKD: overviewPhilip Barter
Pageof 28